1. Home
  2. YAAS vs ACET Comparison

YAAS vs ACET Comparison

Compare YAAS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YAAS
  • ACET
  • Stock Information
  • Founded
  • YAAS 2018
  • ACET 1947
  • Country
  • YAAS China
  • ACET United States
  • Employees
  • YAAS N/A
  • ACET N/A
  • Industry
  • YAAS Computer Software: Prepackaged Software
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • YAAS Technology
  • ACET Health Care
  • Exchange
  • YAAS Nasdaq
  • ACET Nasdaq
  • Market Cap
  • YAAS 59.0M
  • ACET 64.9M
  • IPO Year
  • YAAS 2024
  • ACET N/A
  • Fundamental
  • Price
  • YAAS $3.03
  • ACET $0.67
  • Analyst Decision
  • YAAS
  • ACET Buy
  • Analyst Count
  • YAAS 0
  • ACET 6
  • Target Price
  • YAAS N/A
  • ACET $6.00
  • AVG Volume (30 Days)
  • YAAS 44.0K
  • ACET 412.2K
  • Earning Date
  • YAAS 08-15-2025
  • ACET 08-12-2025
  • Dividend Yield
  • YAAS N/A
  • ACET N/A
  • EPS Growth
  • YAAS N/A
  • ACET N/A
  • EPS
  • YAAS N/A
  • ACET N/A
  • Revenue
  • YAAS $521,240.00
  • ACET N/A
  • Revenue This Year
  • YAAS N/A
  • ACET N/A
  • Revenue Next Year
  • YAAS N/A
  • ACET N/A
  • P/E Ratio
  • YAAS N/A
  • ACET N/A
  • Revenue Growth
  • YAAS N/A
  • ACET N/A
  • 52 Week Low
  • YAAS $1.58
  • ACET $0.45
  • 52 Week High
  • YAAS $4.25
  • ACET $1.70
  • Technical
  • Relative Strength Index (RSI)
  • YAAS N/A
  • ACET 43.24
  • Support Level
  • YAAS N/A
  • ACET $0.72
  • Resistance Level
  • YAAS N/A
  • ACET $0.84
  • Average True Range (ATR)
  • YAAS 0.00
  • ACET 0.06
  • MACD
  • YAAS 0.00
  • ACET -0.02
  • Stochastic Oscillator
  • YAAS 0.00
  • ACET 0.00

About YAAS Youxin Technology Ltd Class A Ordinary shares

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: